| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.6% | |
| Div Cover | 4.0 | |
| Op Mrgn | 23.6% | |
| ROCE | 33.1% |
| Latest | F'cast | |
|---|---|---|
| P/E | 43.9 | |
| PEG | 0.2 | |
| Pr/Revenue | 8.3 | |
| Pr/Book | 4.7 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 15.3% | |
| PBT | 163.7% | |
| EPS | 209.9% | |
| DPS | 2.2% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 5,052.00 | 880.00 | 387.00¢ | 21.8 | n/a | -8% | 127.00¢ | 1.5% |
| 31-Dec-21 | 5,777.00 | 1,226.00 | 560.00¢ | 17.9 | 0.4 | +45% | 130.00¢ | 1.3% |
| 31-Dec-22 | 5,517.00 | 511.00 | 221.00¢ | 33.3 | n/a | -60% | 133.00¢ | 1.8% |
| 31-Dec-23 | 4,867.00 | 441.00 | 181.00¢ | 43.6 | n/a | -18% | 136.00¢ | 1.7% |
| 31-Dec-24 | 5,613.00 | 1,163.00 | 561.00¢ | 34.3 | 0.2 | +210% | 139.00¢ | 0.7% |
| Year Ending | Revenue ( m) | Pre-tax ( m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | 7,143.21 | 1,559.72 | 759.89¢ | 32.4 | 0.9 | +36% | 141.89¢ | 0.0% |
| 31-Dec-26 | 8,166.46 | 2,169.36 | 1,011.36¢ | 24.4 | 0.7 | +33% | 145.90¢ | 0.0% |
| 31-Dec-27 | 9,345.35 | 2,938.04 | 1,307.16¢ | 18.9 | 0.6 | +29% | 149.06¢ | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Belgium's UCB to buy US-based Ra Pharmaceuticals... | 10-Oct-2019 | ShareCast |
| GSK gets emerging markets boost with UCB deal | 24-Jan-2009 | Telegraph |
| UCB confident on drug go-ahead | 21-Aug-2007 | The Scotsman |
| Fellner shuffles Acambis board | 08-Mar-2007 | Telegraph |
| Currency | Euro |
| Share Price | 246.06 |
| Change Today | -0.34 |
| % Change | -0.14 % |
| 52 Week High | 260.20 |
| 52 Week Low | 129.35 |
| Volume | 11,944 |
| Shares Issued | 190.00m |
| Market Cap | 46,752m |
| Beta | 1.81 |
| Strong Buy | 7 |
| Buy | 11 |
| Neutral | 3 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 21 |

| Time | Volume / Share Price |
| 12:00 | 13 @ 246.00 |
| 12:00 | 91 @ 246.00 |
| 11:58 | 1 @ 245.80 |
| 11:58 | 13 @ 245.90 |
| 11:57 | 36 @ 245.90 |
You are here: research